Companies: 10,795·Total market cap: $144.5T
Invictus MD Strategies Corp.

Invictus MD Strategies Corp.

IVITFOTCHealthcare
$0.00
+$0.00(+9900.00%)
Market Cap$4453220
P/E Ratio
52W High$0.0001
52W Low$0.000001
Overview

Invictus MD Strategies Corp. (IVITF) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

IVITF · earnings · updated Jun 9, 2026

Latest Earnings

Q4 FY2019
EPS Actual
-$0.04
Revenue
$0.00B
Fiscal Period
Q4 FY2019
FY ends December
Report Date
Dec 29, 2019
After Market Close
IVITF reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.
Rev. Est.$0.01B

EPS & Revenue vs. Estimates

Actual (Beat)
Actual (Miss)
Estimated

Earnings History

Q4 FY2024
Oct 2, 2024
EPS Actual
EPS Est.
EPS Surpr.
Revenue
Q2 FY2024
Jun 28, 2024
EPS Actual
EPS Est.
EPS Surpr.
Revenue
Q2 FY2024
Apr 3, 2024
EPS Actual
EPS Est.
EPS Surpr.
Revenue
Q1 FY2024
Jan 3, 2024
EPS Actual
EPS Est.
EPS Surpr.
Revenue
Q3 FY2023
Sep 27, 2023
EPS Actual
EPS Est.
EPS Surpr.
Revenue
Q2 FY2023
Jun 30, 2023
EPS Actual
EPS Est.
EPS Surpr.
Revenue
Q1 FY2023
Mar 29, 2023
EPS Actual
EPS Est.
EPS Surpr.
Revenue
Q4 FY2022
Dec 28, 2022
EPS Actual
EPS Est.
EPS Surpr.
Revenue

Analyst Estimates

EPS Estimates
PeriodLowConsensusHigh# Analysts
Q4 FY2024$0.00$0.00$0.000
Q1 FY2019$0.00$0.00$0.000
Revenue Estimates
PeriodLowConsensusHigh# Analysts
Q4 FY2024$0.0B$0.0B$0.0B1
Q1 FY2019$0.0B$0.0B$0.0B1

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.
Q4 FY2019-8.58%
Report Date
Dec 29, 2019
EPS Beat/Miss
Price Before
$0.01
Price After
$0.01
Beat Rate0 / 1 quarters
Largest Move-8.58% (Q4 FY2019)
Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Data source: Financial Modeling Prep (FMP)  |  Updated: Hourly  |  Surprise%: (Actual − Estimate) / |Estimate| × 100  |  Fiscal year: IVITF ends December

Invictus MD Strategies Corp. (IVITF) most recently reported earnings on December 29, 2019 for Q4 FY2019, posting EPS of $-0.04 (in line with the analyst consensus of —). The next IVITF earnings date is expected around September 1, 2026.

Each quarter, investors track IVITF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. IVITF revenue tab →

Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
IVITF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Frequently asked questions

IVITF earnings · 4 questions

Invictus MD Strategies Corp.'s next earnings report is expected around September 1, 2026. IVITF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; IVITF historically reports after market close (AMC).

IVITF earnings datewhen is IVITF earningsIVITF next earnings datewhen does IVITF report earningsIVITF earnings calendar

Source: FMP · Invictus MD Strategies Corp. SEC filings · US GAAP · Invictus MD Strategies Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026